Search Agents MCP CLI

Categories

AIStartupsVentureRobotics

Article Tags

CryptoSpaceEVsBiotechCloud ComputingHardwarePrivacySocial MediaTransportationFundraisingCommerceGovernmentMediaSemiconductorsWearablesDronesQuantum ComputingSaaSDevToolsDataAppsSecurityGadgetsFintechOpen Source

Story Topics

AIOpenAIAnthropicGoogleAppleNvidiaCryptoCybersecurityVenture CapitalRobotics
Entities
Swipe Feed Bookmarks Archive Leaderboard Stats RSS Sitemap
Contact Terms Privacy
Axios · Madison Mills ·

OpenAI acquires Orchestra Bio, which builds AI agents for managing drug development, and plans to integrate its tech into OpenAI life sciences suite Rosalind

OpenAI has acquired Orchestra Bio, a startup building AI agents to help pharmaceutical companies manage drug development, the ChatGPT maker shared exclusively with Axios.

OpenAI AI Biotech
In this story OpenAI Orchestra Bio Rosalind
OpenAI acquires Orchestra Bio, which builds AI agents for managing drug development, and plans to integrate its tech into OpenAI life sciences suite Rosalind

Lead Source

Axios — OpenAI acquires Orchestra Bio, which builds AI agents for managing drug development, and plans to integrate its tech into OpenAI life sciences suite Rosalind ↗

How this story grew

Coverage · 0 Discussion · 0
Oct 20Oct 21

More

OpenAI: OpenAI
TechCrunch: TechCrunch
The Decoder: The Decoder
WOWTALE: WOWTALE
The Neuron: The Neuron

Discussion

Sarah Friar Aashay Sanghvi
@openai @jayrughani @victornunez @ashokaraj_ @kate_rouch @aashaysanghvi_ @cgtwts @sussan_liu @andrewcurran_ @gdb @rand_longevity @joyjiao12 @madisonmills22 @kimmonismus @cpmou2022 @parmita @choblin29 @markchen90 @8vc @rand_longevity @dkrajendra

Related stories

Wall Street Journal: A look at OpenAI-backed Red Queen Bio, an AI biosecurity startup that raised $36M to design antibody drugs against pathogens, including AI-enabled bioweapons
OpenAI: OpenAI, PerturbAI, and Scripps say thousands of GPT-Rosalind agents analyzed data on millions of mouse brain cells in 32 minutes, a job that takes humans months
Bloomberg: Warp Sciences, founded by former OpenAI CPO Kevin Weil to speed up drug development using AI, emerges from stealth with $215M at an $865M post-money valuation
The Information: OpenAI is in early talks to buy Trail of Bits, which finds and fixes vulnerabilities in open-source software; founded in 2012, it has 40+ employees
Wall Street Journal: OpenAI bought Glass Imaging, which is developing AI-powered smartphone camera tech, in a deal valuing it at $300M+; it was valued at ~$100M last year

Discuss with AI

ChatGPT ↗ Claude ↗
← Back to TechSnif